|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
264,900,000 |
Market
Cap: |
8.27(B) |
Last
Volume: |
49,305,461 |
Avg
Vol: |
6,443,121 |
52
Week Range: |
$12.46 - $31.23 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 606 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile ImmunoGen is a clinical-stage biotechnology company focused on developing the antibody-drug conjugates (ADCs). Co.'s main program is mirvetuximab, an ADC targeting folate receptor alpha, a cell-surface protein overexpressed in a number of epithelial tumors, including ovarian, endometrial, and non-small-cell lung cancers. Pivekimab sunirine is an ADC comprised of an antibody designed to target CD123 with site-specific conjugation to a DNA-alkylating payload of the IGN (indolinobenzodiazepine pseudodimer) class. Co.'s pipeline program, IMGC936, is an ADC that is designed to target ADAM9, an enzyme overexpressed in a range of solid tumors and implicated in tumor progression and metastasis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
546,050 |
4,785,085 |
4,785,085 |
Total Sell Value |
$0 |
$15,925,514 |
$86,338,289 |
$86,338,289 |
Total People Sold |
0 |
5 |
5 |
5 |
Total Sell Transactions |
0 |
11 |
26 |
26 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Junius Daniel M |
Chief Executive Officer |
|
2015-04-02 |
4 |
OE |
$5.74 |
$149,998 |
D/D |
26,132 |
124,189 |
|
- |
|
Lambert John |
Executive Vice President |
|
2015-04-01 |
4 |
AS |
$8.74 |
$87,384 |
D/D |
(10,000) |
106,857 |
|
- |
|
Lambert John |
Executive Vice President |
|
2015-04-01 |
4 |
OE |
$5.35 |
$53,500 |
D/D |
10,000 |
116,857 |
|
- |
|
Gregory Richard J. |
Executive VP & CSOOfficer |
|
2015-01-05 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
25,000 |
|
- |
|
Morris Charles Q |
Executive VP & CDO |
|
2014-11-28 |
4 |
AS |
$10.40 |
$54,496 |
D/D |
(5,240) |
32,260 |
|
- |
|
Junius Daniel M |
Chief Executive Officer |
|
2014-09-19 |
4 |
OE |
$5.74 |
$99,997 |
D/D |
17,421 |
98,057 |
|
- |
|
Barrows Craig |
Vice-President,General Counsel |
|
2014-05-05 |
4 |
OE |
$3.30 |
$49,500 |
D/D |
15,000 |
21,100 |
|
- |
|
257 Records found
|
|
Page 11 of 11 |
|
|